Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: May 2008
-
By Donald Zuhn — Earlier today, the technology website Ars Technica posted a report that the Senate patent reform bill (S. 1145) "has been taken off the [Senate] schedule." Because Ars Technica did not provide any additional information, we sought confirmation that the bill was indeed dead — at least as far as…
-
By Kevin E. Noonan — In retrospect, it was eerily prescient. The Wall Street Journal published an article Saturday, hours before the tragedy at Churchill Downs where Eight Belles, a two-year old filly was euthanized because she broke both front ankles after finishing second in the Kentucky Derby. That article was about the…
-
By Donald Zuhn — On April 25th, the State Intellectual Property Office (SIPO) of China announced the launch of an online patent database that allows for English language searches of the bibliographic data and abstracts of published Chinese patent documents. In particular, the database permits one to search the following fields of invention…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Pfizer Inc. et al. v. Teva Pharmaceuticals USA Inc.1:08-cv-00237; filed April 25, 2008 in the District Court of Delaware Infringement of U.S.…
-
May 15, 2008 – The Federal Circuit: A National Court of Appeals: Addressing New Challenges (U.S. Court of Appeals for the Federal Circuit) – Washington, DC May 28, 2008 – Advanced Patent Licensing 2008: What You Need to Know Before Licensing Your Patent (Practising Law Institute) – New York, NY May 28-30, 2008 – PharmaBiotech…
-
By Donald Zuhn — In March, we reported on the lobbying expenditures for a number of biotech and pharmaceutical companies in 2007. For example, we noted that Millennium Pharmaceuticals had spent $1.28 million, Genentech $1.8 million, and AstraZeneca $4.1 million in 2007. Topping each of these companies, however, was Abbott Laboratories, based in…
-
Law Seminars International (LSI) will be holding a Patent Claim Construction workshop on July 16, 2008 in Seattle, Washington. The workshop will provide information on: • Current case law and recent federal circuit developments.• The development of claim construction theory and practice.• Litigation strategies from plaintiff and defendant perspectives.• Managing the prosecution process for the…
-
Practising Law Institute (PLI) will be holding a conference entitled: "Advanced Patent Prosecution Workshop 2008: Claim Drafting & Amendment Writing" on July 24-25, 2008 in New York, NY and on August 11-12, 2008 in San Francisco, CA. The conference will offer presentations on the following topics: • Ethics for Patent Prosecutors• On-Sale Bar• Advanced Claim…
-
By Donald Zuhn — On Wednesday, Pfizer announced that it had received a Notice of Intent to Issue an Ex Parte Reexamination Certificate for U.S. Patent No. 4,681,893 from the U.S. Patent and Trademark Office. The ‘893 patent, which expires in March 2010, is directed in part to atorvastatin, the active ingredient in…
Patent Docs 